Skip to main content
Premium Trial:

Request an Annual Quote

Then Again

23andMe, the direct-to-consumer genetic testing company, has changed its mind about opting users into its program that matches users to relatives, Vox reports.

In a feature last week, Vox recounted the stories of some 23andMe customers who discovered they had close relatives that they didn't know about. One customer found that his father had had a child before he got married, and this, Vox said, contributed to his parents' divorce.

23andMe, Vox had noted, was planning on changing its policy so that new users would automatically opted in to the service and existing customers would be given the option to opt out. "We had many more customers complaining about [relatives not showing up] than discovering someone wasn't related to them," Joanna Mountain, the senior director of research at 23andMe, told Vox then.

But over the weekend, the company announced in a community forum that it had abandoned that idea, and instead would be hiring a chief privacy officer.

"I do not think it was ever the right call to promise that we would automatically opt-in those customers. Core to our philosophy is customer choice and empowerment through data," CEO Anne Wojcicki says in the forum post.

"The Close Relatives features can potentially give a customer life changing information, like the existence of an unknown sibling or the knowledge that a relative is not biologically related to them," she adds. "Customers need to make their own deliberate and informed decision if they want this information."

Wojcicki says that 23andMe will be hiring a chief privacy officer to deal with such issues going forward.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.